Joshua B. Cohen - 12 Sep 2024 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Joshua B. Cohen
Issuer symbol
AMLX
Transactions as of
12 Sep 2024
Net transactions value
+$54,085
Form type
4
Filing time
16 Sep 2024, 17:39:13 UTC
Previous filing
18 Apr 2024
Next filing
25 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Options Exercise $54,085 +34,449 +1.1% $1.57 3,237,301 12 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMLX Stock Option (right to buy) Options Exercise $0 -34,449 -95% $0.000000 1,857 12 Sep 2024 Common Stock 34,449 $1.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.